◐ Shell
reader mode source ↗
Skip to main page content
Full text links Cite
Display options

Abstract

Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science-having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.

Keywords: 3,4-methylenedioxymethamphetamine; MDMA; empathogen; entactogen; psychedelic.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Structural relationships between MDMA and other psychoactive compounds. The common phenethylamine core is highlighted in red. Compounds are classified as psychostimulants, hallucinogens, or entactogens based on the behavioral responses they produce in experimental animals and their subjective effects in humans.
Figure 2.
Figure 2.
Common synthetic strategies used to produce racemic MDMA.
Figure 3.
Figure 3.
Synthetic strategies used to synthesize enantiopure MDMA. (A) Reductive amination using (S)-α-methylbenzylamine (B) Reductive amination using Ellman’s sulfinamide (C) Ring opening of an (S)-alanine-derived-aziridine.
Figure 4.
Figure 4.
Common metabolites of MDMA. CYP = cytochrome P450; COMT = catechol-O-methyltransferase.
Figure 5.
Figure 5.
Timeline of important events related to research on MDMA and classical psychedelics. Note the different peaks for research on MDMA and LSD. The data were obtained from a PubMed search for papers having titles that contained the search terms “3,4-methylenedioxymethamphetamine or MDMA” and “lysergic acid diethylamide or LSD” conducted on March 20, 2018.

References

    1. Shulgin AT (1986) The background and chemistry of MDMA. J. Psychoactive Drugs. 18, 291–304. - PubMed
    1. Palamar JJ (2017) What's in a name? Correlates of ecstasy users knowing or agreeing that molly is ecstasy/MDMA. J. Psychoactive Drugs published online September 22, 2017. DOI: 10.1080/02791072.2017. 1369200. - DOI - PMC - PubMed
    1. Calculated using advanced chemistry development (ACD/Labs) Software V11.02 via SciFinder Scholar.
    1. Pajouhesh H, and Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2, 541–553. - PMC - PubMed
    1. Oberlender R, and Nichols DE, (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology (Berl) 95, 71–76. - PubMed
Show all 265 references

Publication types

MeSH terms

Substances

Grants and funding